思密达和胆维他佐治新生儿高胆红素血症

Neonatal Hyperbilirubinemia Treated by Smeta and Trithioanethol

本文观察24例高胆患儿在常规治疗的基础上加用思密达，胆维他口服治疗。结果24例观察组高胆患儿治疗前血清总胆红素（μmol／L，X±S）为292±47，治疗后17例高胆患儿复查血清总胆红素为87±38。说明能更有效降低血清总胆红素，对高胆具有良好的近期疗效。

24 Neonates with hyperbilirubinemia treated by Smeta and Trithioanethol on the basis of routine treatment were observed in this article. The serum total bilirubin of the 24 patients is 292± 47 (μmol/L)before treatment. In this patients,only 17 patients were reviewed, the serum total bilirubin is 87 ±38(μmol/L). This result indicats that the Smeta and Trithioanethol can drop the serum total bilirubin and have the better effect to treat neonatal hyperbilirubinemia.